Skip to main content

Table 1 Demographic and treatment details

From: Encouraging early outcomes with image guided pencil beam proton therapy for cranio-spinal irradiation: first report from India

Median AGE 8 years (1.5 to 37 years)
Age distribution 0–6 years—15 (37.5%)
7–14 years—16 (40%)
> 14 years— (22.5%)
Sex ratio (M:F) 32:8
Histopathology 20 (50.0%)—Medulloblastoma
7 (17.5%)—Recurrent Ependymoma
3 (7.5%)—Pineoblastoma
3 (7.5%)—Germ cell tumors
7 (17.5%)—Others (ATRT, PNET, APL with CNS involvement and neuroblastoma)
Reirradiation Yes—7 (17.5%)
No—33 (82.5%)
Anesthesia required 6 (15%)—For simulation and complete treatment
2 (5%)—For simulation only
Radiation dose delivered Median dose 23.4 Gy
23.4 Gy—20 (50%)
35 Gy—10 (25%)
Other—10 (25%)
Concurrent chemotherapy Yes—16 (40%)
No—24 (60%)
Chemotherapy agents used Vincristine (81.2%) Carboplatin (18.8%)